SP

Susan Pond

Biotron Limited | Non-Executive Director
Dr Pond has a scientific and commercial background having held executive positions in the biotechnology and pharmaceutical industry for 12 years, recently as chairman and managing director of Johnson & Johnson Research Pty Limited (2003 - 2009). Previous non-executive positions include chair of AusBiotech Limited and director of Australian Nuclear Science and Technology Organisation, Wound Management Innovation CRC and Australian Academy of Technological Sciences and Engineering (ATSE). Dr Pond also served as a board member of Commercialisation Australia and Innovation Australia. Dr Pond is currently director of the Trusted Autonomous Systems Defence Cooperative Research Centre, Vectus Biosystems Ltd and the Australian Phenomics Network. She is a member of the Council of the Queensland University of Technology, the Academy of Technological Sciences & Engineering, the Academy of Health and Medical Sciences and the Royal Society of New South Wales. She obtained specialist clinical credentials in internal medicine, clinical pharmacology and clinical toxicology and held academic appointments at the University of California San Francisco and the University of Queensland before joining industry. Dr Pond was appointed as a director on 7 March 2012.

Companies and Roles

Company
Title
Tenure
Since
BIT
Biotron Limited
  • Non-Executive Director
12yrs, 7mthMar 2012
VBS
Vectus Biosystems Limited
  • Non-Executive Director
8yrs, 5mthMay 2016

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
VBS
Vectus Biosystems Limited
30/08/23N/A40,250N/AN/A
BIT
Biotron Limited
30/06/23N/A785,15465,430N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
VBS
Vectus Biosystems Limited
28/12/22
Issued
18,750$0.800$15,000Participation in share purchase plan
BIT
Biotron Limited
25/11/22
Issued
65,430$0.028$1,832Rights issue
BIT
Biotron Limited
25/11/22
Issued
130,859$0.030$3,925Rights issue
BIT
Biotron Limited
05/12/19
Exercise
109,049$0.050$5,452Exercise of options
BIT
Biotron Limited
05/12/19
Buy
109,049$0.050$5,452Exercise of options